Improvement of goiter volume reduction after 0.3 mg recombinant human thyrotropin-stimulated radioiodine therapy in patients with a very large goiter: A double-blinded, randomized trial

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 9, 2007, Pages 3424-3428

  Bonnema, Steen J ^a   Nielsen, Viveque E ^a   Boel Jørgensen, Henrik ^a   Grupe, Peter ^a   Andersen, Peter B ^a   Bastholt, Lars ^a   Hegedüs, Laszlo ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; PLACEBO; PREDNISOLONE; RADIOACTIVE IODINE; RECOMBINANT THYROTROPIN;

ADULT; AGED; ARTICLE; CERVICOBRACHIAL NEURALGIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG HALF LIFE; DRUG MECHANISM; FEMALE; HUMAN; HYPOTHYROIDISM; MALE; NODULAR GOITER; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REDUCTION; THERAPY EFFECT; TUMOR VOLUME;

EID: 34548787455     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-0501     Document Type: Article

References (27)

1. Vejbjerg P, Knudsen N, Perrild H, Carle A, Laurberg P, Pedersen IB, Rasmussen LB, Ovesen L, Jørgensen T 2007 Effect of a mandatory iodization program on thyroid gland volume based on individuals' age, gender, and preceding severity of dietary iodine deficiency: a prospective, population-based study. J Clin Endocrinol Metab 92:1397-1401
2. Hegedüs L, Bonnema SJ, Bennedbæk FN 2003 Management of simple nodular goiter: current status and future perspectives. Endocr Rev 24:102-132
3. al Suliman NN, Ryttov NF, Qvist N, Blichert-Toft M, Graversen HP 1997 Experience in a specialist thyroid surgery unit: a demographic study, surgical complications, and outcome. Eur J Surg 163:13-20
4. Bonnema SJ, Bennedbæk FN, Wiersinga WM, Hegedüs L 2000 Management of the nontoxic multinodular goitre: a European questionnaire study. Clin Endocrinol (Oxf) 53:5-12
5. Bonnema SJ, Bennedbæk FN, Ladenson PW, Hegedüs L 2002 Management of the nontoxic multinodular goiter: a North American survey. J Clin Endocrinol Metab 87:112-117
6. Diehl LA, Garcia V, Bonnema SJ, Hegedüs L, Albino CC, Graf H 2005 Management of the nontoxic multinodular goiter in Latin America: comparison with North America and Europe, an electronic survey. J Clin Endocrinol Metab 90:117-123
7. Bhagat MC, Dhaliwal SS, Bonnema SJ, Hegedüs L, Walsh JP 2003 Differences between endocrine surgeons and endocrinologists in the management of nontoxic multinodular goitre. Br J Surg 90:1103-1112
8. Nygaard B, Hegedüs L, Gervil M, Hjalgrim H, Søe-Jensen P, Hansen JM 1993 Radioiodine treatment of multinodular non-toxic goitre. Br Med J 307:828-832
9. Le Moli R, Wesche MF, Tiel-Van Buul MM, Wiersinga WM 1999 Determinants of long-term outcome of radioiodine therapy of sporadic non-toxic goitre. Clin Endocrinol (Oxf) 50:783-789
10. Wesche MF, Tiel-Van Buul MM, Lips P, Smits NJ, Wiersinga WM 2001 A randomized trial comparing levothyroxine with radioactive iodine in the treatment of sporadic nontoxic goiter. J Clin Endocrinol Metab 86:998-1005
11. Huysmans DA, Hermus AR, Corstens FH, Barentsz JO, Kloppenborg PW 1994 Large, compressive goiters treated with radioiodine. Ann Intern Med 121:757-762
12. Bonnema SJ, Bertelsen H, Mortensen J, Andersen PB, Knudsen DU, Bastholt L, Hegedüs L 1999 The feasibility of high dose iodine 131 treatment as an alternative to surgery in patients with a very large goiter: effect on thyroid function and size and pulmonary function. J Clin Endocrinol Metab 84:3636-3641
13. Nielsen VE, Bonnema SJ, Boel-Jørgensen H, Grupe P, Hegedüs L 2006 Stimulation with 0.3-mg recombinant human thyrotropin prior to iodine 131 therapy to improve the size reduction of benign nontoxic nodular goiter: a prospective randomized double-blind trial. Arch Intern Med 166:1476-1482
14. Huysmans DA, Nieuwlaat W, Erdtsieck J, Schellekens AP, Bus JW, Bravenboer B, Hermus AR 2000 Administration of a single low dose of recombinant human thyrotropin significantly enhances thyroid radioiodine uptake in nontoxic nodular goiter. J Clin Endocrinol Metab 85:3592-3596
15. 131I therapy of patients with nodular goiter: an evaluation by a randomized double-blinded trial. J Clin Endocrinol Metab 90:79-83
16. Albino CC, Mesa Jr CO, Olandoski M, Ueda CE, Woellner LC, Goedert CA, Souza AM, Graf H 2005 Recombinant human thyrotropin as adjuvant in the treatment of multinodular goiters with radioiodine. J Clin Endocrinol Metab 90:2775-2780
17. Cohen O, Ilany J, Hoffman C, Olchovsky D, Dabhi S, Karasik A, Goshen E, Rotenberg G, Zwas ST 2006 Low-dose recombinant human thyrotropin-aided radioiodine treatment of large, multinodular goiters in elderly patients. Eur J Endocrinol 154:243-252
18. Duick DS, Baskin HJ 2003 Utility of recombinant human thyrotropin for augmentation of radioiodine uptake and treatment of nontoxic and toxic multinodular goiters. Endocr Pract 9:204-209
19. Nieuwlaat WA, Huysmans DA, Van Den Bosch HC, Sweep CG, Ross HA, Corstens FH, Hermus AR 2003 Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter. J Clin Endocrinol Metab 88:3121-3129
20. Silva MN, Rubio IG, Romao R, Gebrin EM, Buchpiguel C, Tomimori E, Camargo R, Cardia MS, Medeiros-Neto G 2004 Administration of a single dose of recombinant human thyrotrophin enhances the efficacy of radioiodine treatment of large compressive multinodular goitres. Clin Endocrinol (Oxf) 60:300-308
21. Bonnema SJ, Andersen PB, Knudsen DU, Hegedüs L 2002 MR imaging of large multinodular goiters: Observer agreement on volume versus observer disagreement on dimensions of the involved trachea. AJR Am J Roentgenol 179:259-266
22. Nielsen VE, Bonnema SJ, Hegedüs L 2006 Transient goiter enlargement after administration of 0.3 mg of recombinant human thyrotropin in patients with benign nontoxic nodular goiter: a randomized, double-blind, crossover trial. J Clin Endocrinol Metab 91:1317-1322
23. Bonnema SJ, Nielsen VE, Hegedüs L 2004 Long-term effects of radioiodine on thyroid function, size and patient satisfaction in non-toxic diffuse goitre. Eur J Endocrinol 150:439-445
24. Bonnema SJ, Nielsen VE, Hegedüs L 2006 Radioiodine therapy in non-toxic multinodular goitre. The possibility of effect-amplification with recombinant human TSH (rhTSH). Acta Oncol 45:1051-1058
25. Nielsen VE, Bonnema SJ, Hegedüs L 2004 The effects of recombinant human thyrotropin, in normal subjects and patients with goitre. Clin Endocrinol (Oxf) 61:655-663
26. Watt T, Grønvold M, Rasmussen AK, Bonnema SJ, Hegedüs L, Bjørner JB, Feldt-Rasmussen U 2006 Quality of life in patients with benign thyroid disorders. A review. Eur J Endocrinol 154:501-510
27. 131I therapy of hyperthyroid diseases: effect on cure rate evaluated by a randomized clinical trial. J Clin Endocrinol Metab 89:4439-4444